In recent years, cell gene therapy has developed rapidly around the world. Because of the particularity of cell gene therapy drugs (live cells are harvested from the human body and then injected into the human body after special processing techniques), their safety has also been highly concerned by regulatory agencies and pharmaceutical companies; at the same time, due to the complexity of their manufacturing process, the cost of manufacturing and quality control is extremely high. The flexible use of digital technology can manage the manufacturing process for compliance and accelerate the safe and effective delivery of drugs to patients.
Focusing on the digitalization of cell therapy, the T-Bio biomedical live broadcast course organized by Taas Labs specially invited Xu Chunli, vice president of Shanghai Singedi Health Technology Co., Ltd., to bring you a live sharing of "digital cell therapy solutions" at 19:30-20:30 on February 16. Online communication is welcome!
Guest profile
Xu Chunli
Singhdi Vice President
Committed to the digitalization of the pharmaceutical industry, with 19 years of experience in the construction of digital factories in the pharmaceutical industry, he has designed and built digital factories for many pharmaceutical companies, including cell therapy, biological drugs, chemical drugs, raw materials, traditional Chinese medicine and other drugs. Participated in the preparation of Shanghai local standards "Information Technology Specifications for Drug Production Quality Management System" and national standards "Industrial Internet of Things Data Acquisition Structured Description Specifications" and other standards. In 2010, he won the third prize of the National Quality Technology Award and in 2014 he won the third prize of the Shanghai Quality Technology Award. Participated in the completion of a number of projects including the national "Eleventh Five-Year" major science and technology project, the national "smart manufacturing" special project, small and medium-sized enterprise innovation funds, and Shanghai information development funds.
speech topic
Digital Solutions for Cell Therapy
Live time
February 16th 19:30-20:30
speech abstract
1. Cell therapy product characteristics and regulatory requirements
2. How to use digital technology to help cell therapy companies achieve compliance, reduce costs and increase efficiency
3. Construction of cell therapy digital factory